BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3113196)

  • 1. Individual Assessment of Brain Tissue Changes in MS and the Effect of Focal Lesions on Short-Term Focal Atrophy Development in MS: A Voxel-Guided Morphometry Study.
    Fox J; Kraemer M; Schormann T; Dabringhaus A; Hirsch J; Eisele P; Szabo K; Weiss C; Amann M; Weier K; Naegelin Y; Kappos L; Gass A
    Int J Mol Sci; 2016 Apr; 17(4):489. PubMed ID: 27043553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corpus Callosum Atrophy in Alcohol-Dependent Men with Memory Disorders and Visual Attention Difficulties.
    Nowaczyk N; Cierpiałkowska L; Mikołajczak M
    J Integr Neurosci; 2023 Dec; 22(6):173. PubMed ID: 38176914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of magnetic resonance imaging in diagnosis and monitoring of treatment in multiple sclerosis.
    Bekiesińska-Figatowska M; Walecki J; Stelmasiak Z
    Acta Neurobiol Exp (Wars); 1996; 56(1):171-6. PubMed ID: 8787171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cranial MR imaging of sequelae of prefrontal lobotomy.
    Uchino A; Kato A; Yuzuriha T; Takashima Y; Kudo S
    AJNR Am J Neuroradiol; 2001 Feb; 22(2):301-4. PubMed ID: 11156773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the corpus callosum size in male individuals with high intelligence quotient (members of Mensa International).
    Urbanik A; Guz W; Gołębiowski M; Szurowska E; Majos A; Sąsiadek M; Stajgis M; Ostrogórska M
    Radiologie (Heidelb); 2023 Nov; 63(Suppl 2):49-54. PubMed ID: 37160478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis.
    Ugga L; Cocozza S; Pontillo G; Russo C; Brescia Morra V; Lanzillo R; Riccio E; Pisani A; Brunetti A
    Brain Behav; 2018 Nov; 8(11):e01121. PubMed ID: 30277321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Note: Poetry, the corpus callosum, and visceral asymmetries.
    McManus IC
    Laterality; 2009 Jul; ():1-4. PubMed ID: 19642050
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical correlates of grey matter pathology in multiple sclerosis.
    Horakova D; Kalincik T; Dusankova JB; Dolezal O
    BMC Neurol; 2012 Mar; 12():10. PubMed ID: 22397707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion tensor group tractography of the corpus callosum in clinically isolated syndrome.
    Lin F; Yu C; Liu Y; Li K; Lei H
    AJNR Am J Neuroradiol; 2011 Jan; 32(1):92-8. PubMed ID: 20966062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load.
    He Y; Dagher A; Chen Z; Charil A; Zijdenbos A; Worsley K; Evans A
    Brain; 2009 Dec; 132(Pt 12):3366-79. PubMed ID: 19439423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and magnetic resonance imaging correlates of corpus callosum in normal pressure hydrocephalus before and after shunting.
    Mataró M; Matarín M; Poca MA; Pueyo R; Sahuquillo J; Barrios M; Junqué C
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):395-8. PubMed ID: 17056634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1.
    Dubovsky EC; Booth TN; Vezina G; Samango-Sprouse CA; Palmer KM; Brasseux CO
    AJNR Am J Neuroradiol; 2001 Jan; 22(1):190-5. PubMed ID: 11158908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.
    Liu C; Edwards S; Gong Q; Roberts N; Blumhardt LD
    J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):323-30. PubMed ID: 10084530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study.
    Barkhof FJ; Elton M; Lindeboom J; Tas MW; Schmidt WF; Hommes OR; Polman CH; Kok A; Valk J
    J Neurol; 1998 Mar; 245(3):153-8. PubMed ID: 9553845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.
    Simon JH
    West J Med; 1996 Jun; 164(6):502-9. PubMed ID: 8764625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data.
    Dietemann JL; Beigelman C; Rumbach L; Vouge M; Tajahmady T; Faubert C; Jeung MY; Wackenheim A
    Neuroradiology; 1988; 30(6):478-80. PubMed ID: 3226533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging.
    Simon JH; Schiffer RB; Rudick RA; Herndon RM
    AJNR Am J Neuroradiol; 1987; 8(4):599-604. PubMed ID: 3113196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR.
    Simon JH; Holtås SL; Schiffer RB; Rudick RA; Herndon RM; Kido DK; Utz R
    Radiology; 1986 Aug; 160(2):363-7. PubMed ID: 3726114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validation study of manual atrophy measures in patients with Multiple Sclerosis.
    Cappelle S; Pareto D; Tintoré M; Vidal-Jordana A; Alyafeai R; Alberich M; Sastre-Garriga J; Auger C; Montalban X; Rovira À
    Neuroradiology; 2020 Aug; 62(8):955-964. PubMed ID: 32246177
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.